mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.45 |
0.009 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |